Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
Identifieur interne : 000087 ( Istex/Corpus ); précédent : 000086; suivant : 000088Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
Auteurs :Source :
- Vaccine [ 0264-410X ] ; 1992.
English descriptors
- Teeft :
- Amino acid sequence, Asialoglycoprotein, Atcc, Attenuated, Avipox, Avipox virus, Biological fluids, Biological samples, Cattle vaccine, Chiron, Continual introduction, Corresponding f1pv peptides, Culturing, Different genogroups serotypes, Distemper, Distemper virus, Distemper virus virogenetics world, Encoding, F1pv, Fecv, Fecv disease, Fecvj, Fecvj optionally, Feline corona virus, Fipv, Fipv exposures, Fipv strains, Fusion partner, Fusion protein expression unit, Galactokinase, Galanthus, Galanthus nivalus agglutinin, Gene expression, Gene segments encoding, Genogroups, Genome, Genomic, Genomic segments, Glycoprotein, Glycosylation, Glycosylation signal, Glycosylationdeficient, Glycosylationdeficient yeast, Haemagglutinin, Hepatitis virus infection, Hepatitis virus infections, Heterotypic, Heterotypic nonhuman animal rotavirus vaccine, Host animal inoculated, Host cell, Hrvs, Human rotavirus, Human rotaviruses, Immunological, Immunological response, Inoculated, Inoculating, Inst, Mannose, Mannose receptor, Measles, Measles virus, Measles virus glycoprotein, Measles virus haemagglutinin glycoprotein, Measles virus haemagglutinin glycoprotein measles virus fusion protein, Morbilli, Morbilli virus, Multiple serotypes, Native fipv exposure, Neutralizing, Neutralizing antibodies, Nivalus, Nonessential, Nonessential region, Nonhuman, Novel method, Novel rotaviruses, Novel vaccines, Optionally, Parental strains, Patent report virus disease, Peptide, Plasmid, Plasmid potskf3, Potskf3, Primary vaccination, Receptor, Recombinant, Recombinant expression, Recombinant protein, Recombinant vaccine, Regulator sequence, Regulatory sequence, Revaccinating, Rotavirus, Rotavirus illness, Rotavirus strains, Rutavirus, Rutavirus illnesses gamble inst, Selectable, Selectable marker, Serotypes, Sialylate, Sialylate glycoproteins, Structural gene encoding, Such vaccines, Tier, Vaccinated, Vaccinated animals, Vaccine, Vaccinia, Vaccinia virus, Virogenetics, Virus, Virus genome, Yeast chiron world.
Url:
DOI: 10.1016/0264-410X(92)90123-2
Links to Exploration step
ISTEX:5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0264-410X(92)90123-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000087</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000087</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</analytic>
<monogr></monogr>
<series><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="1060">1060</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Amino acid sequence</term>
<term>Asialoglycoprotein</term>
<term>Atcc</term>
<term>Attenuated</term>
<term>Avipox</term>
<term>Avipox virus</term>
<term>Biological fluids</term>
<term>Biological samples</term>
<term>Cattle vaccine</term>
<term>Chiron</term>
<term>Continual introduction</term>
<term>Corresponding f1pv peptides</term>
<term>Culturing</term>
<term>Different genogroups serotypes</term>
<term>Distemper</term>
<term>Distemper virus</term>
<term>Distemper virus virogenetics world</term>
<term>Encoding</term>
<term>F1pv</term>
<term>Fecv</term>
<term>Fecv disease</term>
<term>Fecvj</term>
<term>Fecvj optionally</term>
<term>Feline corona virus</term>
<term>Fipv</term>
<term>Fipv exposures</term>
<term>Fipv strains</term>
<term>Fusion partner</term>
<term>Fusion protein expression unit</term>
<term>Galactokinase</term>
<term>Galanthus</term>
<term>Galanthus nivalus agglutinin</term>
<term>Gene expression</term>
<term>Gene segments encoding</term>
<term>Genogroups</term>
<term>Genome</term>
<term>Genomic</term>
<term>Genomic segments</term>
<term>Glycoprotein</term>
<term>Glycosylation</term>
<term>Glycosylation signal</term>
<term>Glycosylationdeficient</term>
<term>Glycosylationdeficient yeast</term>
<term>Haemagglutinin</term>
<term>Hepatitis virus infection</term>
<term>Hepatitis virus infections</term>
<term>Heterotypic</term>
<term>Heterotypic nonhuman animal rotavirus vaccine</term>
<term>Host animal inoculated</term>
<term>Host cell</term>
<term>Hrvs</term>
<term>Human rotavirus</term>
<term>Human rotaviruses</term>
<term>Immunological</term>
<term>Immunological response</term>
<term>Inoculated</term>
<term>Inoculating</term>
<term>Inst</term>
<term>Mannose</term>
<term>Mannose receptor</term>
<term>Measles</term>
<term>Measles virus</term>
<term>Measles virus glycoprotein</term>
<term>Measles virus haemagglutinin glycoprotein</term>
<term>Measles virus haemagglutinin glycoprotein measles virus fusion protein</term>
<term>Morbilli</term>
<term>Morbilli virus</term>
<term>Multiple serotypes</term>
<term>Native fipv exposure</term>
<term>Neutralizing</term>
<term>Neutralizing antibodies</term>
<term>Nivalus</term>
<term>Nonessential</term>
<term>Nonessential region</term>
<term>Nonhuman</term>
<term>Novel method</term>
<term>Novel rotaviruses</term>
<term>Novel vaccines</term>
<term>Optionally</term>
<term>Parental strains</term>
<term>Patent report virus disease</term>
<term>Peptide</term>
<term>Plasmid</term>
<term>Plasmid potskf3</term>
<term>Potskf3</term>
<term>Primary vaccination</term>
<term>Receptor</term>
<term>Recombinant</term>
<term>Recombinant expression</term>
<term>Recombinant protein</term>
<term>Recombinant vaccine</term>
<term>Regulator sequence</term>
<term>Regulatory sequence</term>
<term>Revaccinating</term>
<term>Rotavirus</term>
<term>Rotavirus illness</term>
<term>Rotavirus strains</term>
<term>Rutavirus</term>
<term>Rutavirus illnesses gamble inst</term>
<term>Selectable</term>
<term>Selectable marker</term>
<term>Serotypes</term>
<term>Sialylate</term>
<term>Sialylate glycoproteins</term>
<term>Structural gene encoding</term>
<term>Such vaccines</term>
<term>Tier</term>
<term>Vaccinated</term>
<term>Vaccinated animals</term>
<term>Vaccine</term>
<term>Vaccinia</term>
<term>Vaccinia virus</term>
<term>Virogenetics</term>
<term>Virus</term>
<term>Virus genome</term>
<term>Yeast chiron world</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>vaccine</json:string>
<json:string>rotavirus</json:string>
<json:string>recombinant</json:string>
<json:string>atcc</json:string>
<json:string>fipv</json:string>
<json:string>fecv</json:string>
<json:string>encoding</json:string>
<json:string>glycoprotein</json:string>
<json:string>morbilli virus</json:string>
<json:string>morbilli</json:string>
<json:string>serotypes</json:string>
<json:string>distemper</json:string>
<json:string>receptor</json:string>
<json:string>haemagglutinin</json:string>
<json:string>human rotaviruses</json:string>
<json:string>culturing</json:string>
<json:string>vaccinia</json:string>
<json:string>vaccinia virus</json:string>
<json:string>biological samples</json:string>
<json:string>mannose</json:string>
<json:string>peptide</json:string>
<json:string>measles</json:string>
<json:string>heterotypic</json:string>
<json:string>hepatitis virus infections</json:string>
<json:string>native fipv exposure</json:string>
<json:string>vaccinated</json:string>
<json:string>vaccinated animals</json:string>
<json:string>fipv exposures</json:string>
<json:string>fipv strains</json:string>
<json:string>f1pv</json:string>
<json:string>corresponding f1pv peptides</json:string>
<json:string>attenuated</json:string>
<json:string>feline corona virus</json:string>
<json:string>rotavirus strains</json:string>
<json:string>rutavirus</json:string>
<json:string>inst</json:string>
<json:string>rutavirus illnesses gamble inst</json:string>
<json:string>fecvj</json:string>
<json:string>hrvs</json:string>
<json:string>genomic</json:string>
<json:string>genomic segments</json:string>
<json:string>parental strains</json:string>
<json:string>genogroups</json:string>
<json:string>galactokinase</json:string>
<json:string>different genogroups serotypes</json:string>
<json:string>novel rotaviruses</json:string>
<json:string>amino acid sequence</json:string>
<json:string>novel vaccines</json:string>
<json:string>human rotavirus</json:string>
<json:string>multiple serotypes</json:string>
<json:string>such vaccines</json:string>
<json:string>novel method</json:string>
<json:string>tier</json:string>
<json:string>neutralizing</json:string>
<json:string>neutralizing antibodies</json:string>
<json:string>primary vaccination</json:string>
<json:string>rotavirus illness</json:string>
<json:string>revaccinating</json:string>
<json:string>patent report virus disease</json:string>
<json:string>nonhuman</json:string>
<json:string>heterotypic nonhuman animal rotavirus vaccine</json:string>
<json:string>cattle vaccine</json:string>
<json:string>gene segments encoding</json:string>
<json:string>optionally</json:string>
<json:string>fecvj optionally</json:string>
<json:string>recombinant protein</json:string>
<json:string>fecv disease</json:string>
<json:string>fusion partner</json:string>
<json:string>measles virus haemagglutinin glycoprotein</json:string>
<json:string>host cell</json:string>
<json:string>virogenetics</json:string>
<json:string>distemper virus virogenetics world</json:string>
<json:string>nonessential</json:string>
<json:string>nonessential region</json:string>
<json:string>genome</json:string>
<json:string>virus genome</json:string>
<json:string>immunological</json:string>
<json:string>immunological response</json:string>
<json:string>inoculated</json:string>
<json:string>host animal inoculated</json:string>
<json:string>inoculating</json:string>
<json:string>measles virus</json:string>
<json:string>measles virus haemagglutinin glycoprotein measles virus fusion protein</json:string>
<json:string>measles virus glycoprotein</json:string>
<json:string>plasmid</json:string>
<json:string>potskf3</json:string>
<json:string>avipox</json:string>
<json:string>avipox virus</json:string>
<json:string>recombinant vaccine</json:string>
<json:string>distemper virus</json:string>
<json:string>continual introduction</json:string>
<json:string>hepatitis virus infection</json:string>
<json:string>plasmid potskf3</json:string>
<json:string>gene expression</json:string>
<json:string>chiron</json:string>
<json:string>yeast chiron world</json:string>
<json:string>asialoglycoprotein</json:string>
<json:string>galanthus</json:string>
<json:string>nivalus</json:string>
<json:string>galanthus nivalus agglutinin</json:string>
<json:string>fusion protein expression unit</json:string>
<json:string>glycosylationdeficient</json:string>
<json:string>glycosylationdeficient yeast</json:string>
<json:string>recombinant expression</json:string>
<json:string>structural gene encoding</json:string>
<json:string>glycosylation</json:string>
<json:string>glycosylation signal</json:string>
<json:string>regulatory sequence</json:string>
<json:string>selectable</json:string>
<json:string>selectable marker</json:string>
<json:string>sialylate</json:string>
<json:string>sialylate glycoproteins</json:string>
<json:string>biological fluids</json:string>
<json:string>regulator sequence</json:string>
<json:string>mannose receptor</json:string>
<json:string>virus</json:string>
</teeft>
</keywords>
<arkIstex>ark:/67375/6H6-VBJP2WNJ-F</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Patent report</json:string>
</originalGenre>
<qualityIndicators><score>2.695</score>
<pdfWordCount>683</pdfWordCount>
<pdfCharCount>4167</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>1</pdfPageCount>
<pdfPageSize>612 x 864 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
<pii><json:string>0264-410X(92)90123-2</json:string>
</pii>
<genre><json:string>other</json:string>
</genre>
<host><title>Vaccine</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>1992</publicationDate>
<issn><json:string>0264-410X</json:string>
</issn>
<pii><json:string>S0264-410X(00)X0194-6</json:string>
</pii>
<volume>10</volume>
<issue>14</issue>
<pages><first>1060</first>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1992</json:string>
</date>
<geogName></geogName>
<orgName></orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName></persName>
<placeName></placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/6H6-VBJP2WNJ-F</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - medicine, research & experimental</json:string>
<json:string>2 - immunology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - virology</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Infectious Diseases</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Public Health, Environmental and Occupational Health</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Veterinary</json:string>
<json:string>3 - General Veterinary</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Immunology and Microbiology</json:string>
<json:string>3 - General Immunology and Microbiology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
</scopus>
</categories>
<publicationDate>1992</publicationDate>
<copyrightDate>1992</copyrightDate>
<doi><json:string>10.1016/0264-410X(92)90123-2</json:string>
</doi>
<id>5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability><licence><p>elsevier</p>
</licence>
</availability>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p>
<date>1992</date>
</publicationStmt>
<notesStmt><note type="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note type="content">Section title: Patent report</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a">Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
<idno type="istex">5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6</idno>
<idno type="ark">ark:/67375/6H6-VBJP2WNJ-F</idno>
<idno type="DOI">10.1016/0264-410X(92)90123-2</idno>
<idno type="PII">0264-410X(92)90123-2</idno>
</analytic>
<monogr><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="pISSN">0264-410X</idno>
<idno type="PII">S0264-410X(00)X0194-6</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992"></date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="1060">1060</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1992</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
<revisionDesc><change when="1992">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier converted-article found"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="pnt"><item-info><jid>JVAC</jid>
<aid>92901232</aid>
<ce:pii>0264-410X(92)90123-2</ce:pii>
<ce:doi>10.1016/0264-410X(92)90123-2</ce:doi>
<ce:copyright type="other" year="1992"></ce:copyright>
</item-info>
<head><ce:dochead><ce:textfn>Patent report</ce:textfn>
</ce:dochead>
<ce:title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</ce:title>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</titleInfo>
<typeOfResource>text</typeOfResource>
<genre type="other" displayLabel="Patent report" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1992</dateIssued>
<copyrightDate encoding="w3cdtf">1992</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<note type="content">Section title: Patent report</note>
<relatedItem type="host"><titleInfo><title>Vaccine</title>
</titleInfo>
<titleInfo type="abbreviated"><title>JVAC</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1992</dateIssued>
</originInfo>
<identifier type="ISSN">0264-410X</identifier>
<identifier type="PII">S0264-410X(00)X0194-6</identifier>
<part><date>1992</date>
<detail type="volume"><number>10</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>14</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages"><start>969</start>
<end>1078</end>
</extent>
<extent unit="pages"><start>1060</start>
</extent>
</part>
</relatedItem>
<identifier type="istex">5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6</identifier>
<identifier type="ark">ark:/67375/6H6-VBJP2WNJ-F</identifier>
<identifier type="DOI">10.1016/0264-410X(92)90123-2</identifier>
<identifier type="PII">0264-410X(92)90123-2</identifier>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/record.json</uri>
</json:item>
</metadata>
<author></author>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000087 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000087 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6 |texte= Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |